Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Is GAL-101 the Future of AMD Treatment?
Research & Development Is GAL-101 the Future of AMD Treatment?

The world of ophthalmology faces a promising yet complex challenge as it navigates the treatment of age-related macular degeneration (AMD), a leading cause of vision loss across the globe. In recent years, advancements in medical research have unveiled new pathways to tackle this degenerative

LabGenius Welcomes Dr. Sinclair as New CSO to Drive Antibody Innovation
Tech & Innovation LabGenius Welcomes Dr. Sinclair as New CSO to Drive Antibody Innovation

How does a single leadership appointment hold the potential to change the trajectory of cancer drug discovery? The appointment of Dr. Angus Sinclair as the Chief Scientific Officer at LabGenius is poised to redefine the future of therapeutic antibodies, with implications that could resonate

Ancient DNA Study Redefines Early South African History
Research & Development Ancient DNA Study Redefines Early South African History

A recent study involving ancient DNA analysis has fundamentally reshaped the understanding of early human history in South Africa. By examining DNA from nine prehistoric skeletons unearthed in the Oakhurst rock shelter, researchers have been able to reconstruct a more comprehensive picture of the

Can AI Revolutionize Breast Cancer Diagnosis and Treatment?
Tech & Innovation Can AI Revolutionize Breast Cancer Diagnosis and Treatment?

The Hong Kong University of Science and Technology has recently unveiled a groundbreaking artificial intelligence tool named the Mixture of Modality Experts (MOME), promising to significantly advance breast cancer diagnosis and management. Designed to match the precision of seasoned radiologists,

Neurology's 2025 Leap: Neuroprotection and Patient-Centric Care
Research & Development Neurology's 2025 Leap: Neuroprotection and Patient-Centric Care

The landscape of neurology is undergoing a seismic shift as new advancements in research and treatment redefine approaches to longstanding neurological diseases. Historically, the focus has been on managing symptoms, often overlooking deeper disease mechanisms and progression. Today, this is

Optiscan Pioneers Real-Time Digital Microscopic Imaging
Tech & Innovation Optiscan Pioneers Real-Time Digital Microscopic Imaging

In a world where technology continually transforms medical practices, Optiscan stands out as a trailblazer in real-time digital microscopic imaging. Over the years, this Australian-based global medical technology manufacturer has elevated traditional diagnostic methods, offering unprecedented

Integration Boosts Livestock Health and Biosecurity Solutions
Biotech & Bioprocessing Integration Boosts Livestock Health and Biosecurity Solutions

As diseases increasingly threaten global livestock health, the convergence of biosecurity measures and nutritional strategies becomes crucial for sustainable farming. The recent merger between Biocidas Biodegradables Zix (BBZIX) and Roam Technology exemplifies a strategic response to these

BioSafety Officer Role at Algoma University: Key Responsibilities
Biotech & Bioprocessing BioSafety Officer Role at Algoma University: Key Responsibilities

Algoma University continues to uphold its commitment to maintaining a safe and inclusive environment for its community through the essential role of the BioSafety Officer. Positioned within the Life, Health & Safety department at the institution's Sault Ste Marie campus, this role is pivotal to

How Can We Boost Psychosis Patient Recruitment in Clinical Trials?
Research & Development How Can We Boost Psychosis Patient Recruitment in Clinical Trials?

Recruiting patients diagnosed with psychosis for clinical trials poses distinct challenges due to the complexities associated with the disorder itself and systemic barriers within healthcare systems. Despite the significant need for advancing treatment methodologies for psychosis, the recruitment

Synthetic Biology and Biodiversity: Policy Shifts and Global Goals
Biotech & Bioprocessing Synthetic Biology and Biodiversity: Policy Shifts and Global Goals

Amidst rising global environmental challenges, the world is beginning to recognize synthetic biology as a pivotal tool in biodiversity conservation. This change marks significant progress within the Convention on Biological Diversity (CBD) framework, which originally viewed biotechnological

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later